Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:32:43.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the eligible conditions in the study description. The study now targets FRα-expressing tumors across ovarian, primary peritoneal, and fallopian tube cancers.
    Difference
    0.0%
    Check dated 2026-02-18T07:25:05.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the site. The previous Revision: v3.4.1 entry and the outdated government operating-status notice were removed; no changes to the study content.
    Difference
    0.2%
    Check dated 2026-02-11T09:27:59.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH operating status was added. The site revision indicator changed from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T05:50:33.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary option, a new Last Update Submitted that Met QC Criteria timestamp, and a No FEAR Act Data notice with Revision: v3.4.0. The prior Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-28T04:15:01.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4; a minor template/version update from v3.3.3 to v3.3.4 with no user-facing changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:59:01.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.